Arterez management team, advisors, providers and counsel were carefully selected to guide our technologies as well as business growth and partnership objectives.  

Management Team


Dr. Joe Tunac

Chairman and President

Dr. Tunac is a medical scientist specializing in the discovery and development of drugs and has 40 years of drug development experience for Merck, Warren Lambert Park Davis, Fermical and Farmaceutix where he discovered the anti-embolic mechanism.  30+ patents and patents pending and more than 35 scientific publications.  Graduate studies at S. Dakota St. and Penn St.,  doctorate from Rutgers, NJ; The Waksman Institute: the birthplace of antibiotics


Mike Brennan

Chief Executive Officer

Mike is a serial entrepreneur and team leader with 15 years experience managing 24/7 high-tech operations followed by 15 years of entrepreneurship and strategic advisory  leading, funding, growing and commercializing innovations across the spectrum of industries and technologies including startups and turnarounds.  Mike graduated from The University of Detroit Jesuit (go Cubs), and attended Western Michigan; Psychology/Business Admin, U of D Mercy; Cam Design and the University of Michigan; Entrepreneurial Development program.


Brett Homovec

Chief Financial Officer

Brett gained his Corporate Finance/Mergers and Acquisitions experience as a VP in the Investment Banking Group for Rodman & Renshaw in New York and Chicago, Senior Associate in the Dean Witter Reynolds Corp Finance Group and as an audit professional for Touche Ross & Co. in New York.  Brett graduated from Dartmouth College with a B.A. in Economics and received his MBA in Finance from New York University - Stern School of Business.


Jim Smith, PhD

Chief Science Officer

Jim brings 29 years of biomedical research, business, academic, pharmaceutical and biotech experience.  He attended Eastern Michigan University and completed his doctoral studies at the University of Texas, Southwestern with post-doctoral training at the University of Arizona.  Dr. Smith served at the UM Medical School with a joint appointment in Anesthesiology and Pharmacology.  He moved to Pfizer as a clinical scientist and also served as a director.

Advisory Board


Mr. Xxx Xxxxxx


Xxxxx X. Xxxxxx, M.D. 


Mr. Xxxxxx Xxxxx 


Xxxxxxx X. Xxxxx, M.D. 


Xxxx Xxxxxx, M.D.


Xxxxxx, X. Xxxx. M.D.

To be


July, 2020

To be


July, 2020

To be


July, 2020

To be


July, 2020

To be


July, 2020

To be


July, 2020

Partner Providers

API Development & Manufacturing

Bio Specimen Sourcing 

Preclinical Toxicology

Pre-clinical & Translational Studies

ELISA Research 

ELISA, Stability studies

Company Counsel 

General Counsel

Intellectual Properties

Trademarks & Copyrights

Corporate Counsel

Accounting and Tax

© 2020  All Copyrights Reserved, Arterez, LLC